Keating Financial Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Keating Financial Advisory Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$859K	Sell	3,466 -106	-3%	-$22.8K	0.11%	124
2026 Q1	$717K	Buy	3,572 +857	+32%	+$177K	0.12%	120
2025 Q4	$561K	Buy	+2,715	New	+$543K	0.08%	196

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Keating Financial Advisory Services's FBT Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3% in Q2 2026, selling an estimated $22.8K and leaving 3,466 shares worth $859K. The position accounts for 0.11% of the portfolio, ranked #124.

Keating Financial Advisory Services first reported a position in FBT in Q4 2025 and has held it in 3 quarters since. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Keating Financial Advisory Services held 3,466 shares of First Trust NYSE Arca Biotechnology Index Fund worth $859K as of Q2 2026.
Keating Financial Advisory Services sold 106 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $22.8K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.11% of Keating Financial Advisory Services's portfolio in Q2 2026, its #124 holding.
Keating Financial Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 3 quarters since.
340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.